William L Herring (W L Herring)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Sickle Cell Disease

Affordable Care Act

Prognostic Factors

Top Venues

PharmacoEconomics

Journal of medical economics

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Kyle Paret, Hadi Beyhaghi, William L Herring, Josephine Mauskopf, Lesley G Shane, Matthew D Rousculp
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States. Vaccines 12 (1) (2024)
William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Olivia M Dong, Anjulika Chawla, Jennifer W Leiding, Lixin Zhang, Clark Paramore, Biree Andemariam
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics 42 (6) (2024)
Kyle Paret, Hadi Beyhaghi, William L Herring, Josephine Mauskopf, Lesley G Shane, Matthew D Rousculp
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States. Vaccines 12 (1) (2024)
William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Olivia M Dong, Anjulika Chawla, Jennifer W Leiding, Lixin Zhang, Clark Paramore, Biree Andemariam
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics (2024)
Kyle Paret, Hadi Beyhaghi, William L Herring, Josephine Mauskopf, Lesley G Shane, Matthew D Rousculp
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States. Vaccines 12 (1) (2024)
William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Olivia M Dong, Anjulika Chawla, Jennifer W Leiding, Lixin Zhang, Clark Paramore, Biree Andemariam
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics 42 (6) (2024)
William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Olivia M Dong, Anjulika Chawla, Jennifer W Leiding, Lixin Zhang, Clark Paramore, Biree Andemariam
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics 42 (6) (2024)
William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Olivia M Dong, Anjulika Chawla, Jennifer W Leiding, Lixin Zhang, Clark Paramore, Biree Andemariam
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics 42 (6) (2024)
Timothy Spelman, William L Herring, Carlos Acosta, R Hyde, Vilija G Jokubaitis, E Pucci, A Lugaresi, G Laureys, E K Havrdova, D Horakova, G Izquierdo, S Eichau, S Ozakbas, R Alroughani, T Kalincik, P Duquette, M Girard, T Petersen, Francesco Patti, Tünde Csépány, F Granella, F Grand'Maison, D Ferraro, R Karabudak, M Jose Sa, M Trojano, V van Pesch, B Van Wijmeersch, E Cartechini, P McCombe, O Gerlach, D Spitaleri, C Rozsa, S Hodgkinson, R Bergamaschi, R Gouider, A Soysal, T Castillo-Triviño, J Prevost, J Garber, K de Gans, R Ampapa, M Simo, J L Sanchez-Menoyo, G Iuliano, A Sas, A van der Walt, N John, O Gray, S Hughes, G De Luca, M Onofrj, K Buzzard, O Skibina, M Terzi, M Slee, C Solaro, C Oreja-Guevara, C Ramo-Tello, Y Fragoso, V Shaygannejad, F Moore, C Rajda, E Aguera Morales, H Butzkueven
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom. Journal of medical economics (2023)
William L Herring, Ian Gopal Gould, Villum Wittrup-Jensen, Judith Ertle, Effie Kuti, Sorrel Wolowacz
Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes. Journal of comparative effectiveness research (2022)